References
- Canadian Institutes of Health Research [online]. Available at: http://www.cihr-irsc.gc.ca/e/48413.html. Accessed July 12, 2019.
- UK National Institute of Health Research INVOLVE [online]. Available at: http://www.invo.org.uk. Accessed September 21, 2019.
- The National Health and Medical Research Council in collaboration with the Consumers Health Forum of Australia. Summary statement on consumer and community participation in health and medical research [online]. Available at: https://www.nhmrc.gov.au/sites/default/files/documents/reports/consumer-community-involvement.pdf. Accessed July 12, 2019.
- Frank L, Forsythe L, Ellis L, Schrandt S, Sheridan S, Gerson J. Conceptual and practical foundations of patient engagement in research at the patient-centered outcomes research institute. Qual Life Res. 2015;24:1033–41.
- European Patient’s Academy [online]. Available at: https://www.eupati.eu. Accessed September 21, 2019.
- Oliver S, Clarke-Jones L, Rees R, Milne R, Buchanan P, Gabbay J, et al. Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. Health Technol Assess. 2004;8:1–148.
- Swartz LJ, Callahan KA, Butz AM, Rand CS, Kanchanaraksa S, Diette GB, et al. Methods and issues in conducting a community-based environmental randomized trial. Environ Res. 2004;95:156–65.
- Shagi C, Vallely A, Kasindi S, Chiduo B, Desmond N, Soteli S, et al. A model for community representation and participation in HIV prevention trials among women who engage in transactional sex in Africa. AIDS Care. 2008;20:1039–49.
- Mader L, Harris T, Klager S, Wilkinson I, Hiemstra T. Inverting the patient involvement paradigm: defining patient led research. Res Involv Engagem. 2018;4:21.
- Armstrong M, Mullins C, Gronseth G, Gagliardi A. Impact of patient involvement on clinical practice guideline development: a parallel group study. Implementation Sci. 2018;13:55.
- Edwards V, Wyatt K, Logan S, Britten N. Consulting parents about the design of a randomized controlled trial of osteopathy for children with cerebral palsy. Health Expect. 2011;14:429–38.
- Domecq J, Prutsky G, Elraiyah T, Wang Z, Nabhan M, Shippee N, et al. Patient engagement in research: a systematic review. BMC Health Serv Res. 2014;14:89.
- Crocker J, Ricci-Cabello I, Parker A, Hirst J, Chant A, Petit-Zeman S, et al. Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis. BMJ. 2018;36:k4738.
- Levitan B, Getz K, Eisenstein E, Goldberg M, Harker M, Hesterlee S, et al. Assessing the financial value of patient engagement: a quantitative approach from CTTI’s patient groups and clinical trials project. Drug Inf J. 2018;52:220–9.
- Bedlack RS, Pastula DM, Welsh E, Pulley D, Cudkowicz M. Scrutinizing enrollment in ALS clinical trials: Room for improvement? Amyotroph Lateral Scler. 2008;9:257–65.
- Bedlack RS, Wicks P, Heywood J, Kasarskis E. Modifiable barriers to enrollment in American ALS research studies. Amyotroph Lateral Scler. 2010;11:502–7.
- American Medical Association Council on Scientific Affairs. Viability of cancer clinical research: patient accrual, coverage, and reimbursement. J Natl Cancer Inst 1991;83:254–9.
- The Cancer Letter. To improve clinical trials participation, groups plan an awareness campaign. Cancer Lett. 2000;26:1–3.
- Ellis P. Attitudes toward participation in randomized clinical trials in oncology: a review of the literature. Ann Oncol. 2000;11:939–45.
- Comis RL, Miller JD, Aldigé CR, Krebs L, Stoval E. Public attitudes toward participation in cancer clinical trials. JCO. 2003;21:830–5.
- Lara PN, Jr, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. JCO. 2001;19:1728–33.
- Lukovits TG, Thomas K, Gorelick PB. Stroke prevention trials: How many enrollees can be expected by site? Neurology 1999;52:1101.
- Parkinson’s Foundation [online]. Available at: https://www.parkinson.org/research/Patient-Engagement/Advocate-for-Research?_ga=2.248494343.1838923597.1562786242-106325765.1555962682. Accessed July 15, 2019.
- ALS Association [online]. Available at: http://www.alsa.org. Accessed July 15, 2019.
- ALS Hope Foundation [online]. Available at: https://www.alshf.org. Accessed July 15, 2019.
- Northeast ALS Consortium [online]. Available at: https://www.neals.org/for-people-with-als-caregivers/educational-webinars/. Accessed July 15, 2015.
- According to ALS Research Ambassador Rick Isaacs (personal communication April 2015).
- Sohn E. The ice bucket challenge delivers. Nature 2017;550:s113.
- Hrastelj J, Robertson N. Ice bucket challenge bears fruit for amyotrophic lateral sclerosis. J Neurol. 2016;263:2355–7.
- Personal communication between Pat Quinn and Richard Bedlack, September 23, 2019.
- ALS Association Advocacy Conference. [online]. Available at: http://www.alsa.org/advocacy/advocacy-day/. Accessed July 15, 2015.
- Turner M, Kiernan M, Leigh N, Talbot K. National registry offers new hope for ALS. Lancet Neurol 2009;8:1.
- Department of Defense congressionally directed medical research programs [online]. Available at: https://cdmrp.army.mil/alsrp/highlights. Accessed July 15, 2015.
- Personal communication between Allison Pogemiller and Richard Bedlack, September 23, 2019
- Personal communication between Shelly Hoover and Richard Bedlack, September 23, 2019
- Northeast ALS Consortium [online]. Available at: https://www.neals.org/als-trials/search-for-a-trial/. Accessed September 23, 2019.
- Van den Berg L, Sorenson E, Gronseth G, Macklin E, Andrerws J, Baloh R, et al. Revised Arlie House consensus guidelines for design and implementation of ALS clinical trials. Neurology 2019;92:e1610–23.
- Personal communication between Cris Simon and Richard Bedlack, 23 September 2019.
- ALS Association Patient-Focused Guidance for Drug Development [online]. Available at: http://www.alsa.org/advocacy/fda/. Accessed July 15, 2015.
- I Am ALS [online]. Available at: https://iamals.org/wp-content/uploads/2019/09/Community-Priorities-FDA-ALS-Guidance-Recommendations.pdf. Accessed September 23, 2019.
- United States Food and Drug Administration [online]. Available at: https://www.fda.gov/media/130964/download. Accessed September 23, 2019.
- Twitter [online]. Available at: https://twitter.com/bsw5020/status/1172887680176328710. Accessed Septemberr 23, 2019.
- Bedlack RS, Wicks P, Vaughan T, Opie A, Blum R, Dios A, et al. Lunasin does not slow ALS progression: results of an open-label, single-center, hybrid-virtual 12-month trial. Amyotroph Lateral Scler. 2019;20:285–93.
- Berry J, Bedlack R, Matthews D, Agnese W, Apple S. Engaging ALS Research Ambassadors to Help Design the REFINE-ALS Biomarker Study. Presented at Muscle Study Group Annual Scientific Meeting, September 20–2, 2019.
- Personal communication between Madeline Kennedy and Richard Bedlack, 28 September 2019.
- Northeast ALS Consortium [online]. Available at: https://www.neals.org. Accessed July 15, 2015.
- Musson L, McDermott C, Hobson E. Exploring patient and public involvement in motor neuron disease research. Amyotroph Lateral Scler 2019;20:511–20.